Related Experiment Video

Updated: May 27, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Bacteremia and MR-proANP changes in mild community-acquired pneumonia

Solweig Guinard-Barbier1, Camille Chenevier-Gobeaux, Sophie Grabar

  • 1Department of Emergency Medicine, Groupe Hospitalier Broca Cochin Hôtel-Dieu, Paris, France.

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|November 23, 2011
PubMed
Abstract

Insights

Mid-regional pro-atrial natriuretic peptide (MR-proANP) levels were slightly higher in community-acquired pneumonia (CAP) patients with bacteremia. However, MR-proANP poorly predicts bacteremia in CAP.

Area of Science:

  • Biomarkers in Infectious Diseases
  • Cardiovascular Physiology
  • Respiratory Medicine

Background:

  • Mid-regional pro-atrial natriuretic peptide (MR-proANP) levels correlate with community-acquired pneumonia (CAP) severity.
  • Investigating novel biomarkers for predicting complications in CAP is crucial.

Purpose of the Study:

  • To determine if MR-proANP levels correlate with the presence of bacteremia in CAP patients.
  • To evaluate the diagnostic performance of MR-proANP for bacteremia detection in CAP.

Main Methods:

  • Prospective observational multicenter study.
  • Inclusion of 392 adult patients with CAP presenting to the emergency department.
  • Analysis of MR-proANP levels in relation to blood culture results.

Main Results:

  • MR-proANP levels were significantly higher in patients with bacteremia (92.8 pmol/L) compared to those without (84.3 pmol/L, p=0.04).
  • The diagnostic performance of MR-proANP for bacteremia was comparable to C-reactive protein (CRP) (0.60 vs. 0.59).
  • MR-proANP showed lower accuracy than procalcitonin (PCT) in detecting bacteremia (0.60 vs. 0.69).

Conclusions:

  • MR-proANP demonstrates a poor predictive value for bacteremia in patients with CAP.
  • While elevated in bacteremic CAP, MR-proANP is not a reliable standalone biomarker for this complication.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...